AT EVERY STEP OF THE RESEARCH PROCESS FROM THE LAB TO THE CLINIC, WE ARE PURSUING INNOVATIVE WAYS TO PREVENT AND CONTROL CANCER.
Ludwig Chicago's Ralph Weichselbaum and colleagues reveal how tumors grow resistant to radiotherapy—and how to preempt that resistance.
Here’s a brief highlights video of the symposium held in Oxford in September 2017 to celebrate the 10th anniversary of the Ludwig Oxford Branch.
Ludwig Brussels study uses a unique approach to expose a potent mechanism by which melanoma tumors resist a variety of promising immunotherapies. The study also shows how this mechanism might be disabled by drugs currently in clinical development.